/

Empresas

Si

No verificado

Sirius Therapeutics

Sobre qué escribimos

BiotecnologíaCardiologíaFarmacéuticaMedicina - VariosSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa

09/05/2025

Salud

Medicina - Varios

Sanidad

Farmacéutica

Cardiología

Biotecnología

Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases

Fuente

Sirius Therapeutics

Editor

1.00

0

10/12/2024

Ferias y Congresos

Industria

Salud

Medicina - Varios

Sanidad

Farmacéutica

Cardiología

Biotecnología

Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders

Fuente

Sirius Therapeutics

Editor

1.00

0

03/12/2024

Eventos

Industria

Salud

Biotecnología

Medicina - Varios

Farmacéutica

Cardiología

Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition

Fuente

Sirius Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0